Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
45
EVH Quote, Financials, Valuation and Earnings
Last price:
$11.28
Seasonality move
:
4.5%
Day range:
$11.23 - $11.81
52-week range:
$7.06 - $33.63
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.54x
P/B ratio:
1.41x
Volume:
2M
Avg. volume:
2.8M
1-year change:
-45.95%
Market cap:
$1.3B
Revenue:
$2.6B
EPS (TTM):
-$1.23
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $924.6M | $908M | $1.4B | $2B | $2.6B | |
| Revenue Growth (YoY) | 34.57% | -1.8% | 48.91% | 45.26% | 30.09% | |
| Cost of Revenues | $696.6M | $657.6M | $1B | $1.5B | $2.2B | |
| Gross Profit | $228.1M | $250.4M | $316.6M | $460.5M | $367.4M | |
| Gross Profit Margin | 24.67% | 27.58% | 23.42% | 23.45% | 14.38% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $210.4M | $219.5M | $269.3M | $358.1M | $263.1M | |
| Other Inc / (Exp) | -$261.7M | $24.3M | -$28M | -$132.4M | -$29.8M | |
| Operating Expenses | $271.2M | $279.5M | $336.5M | $481.5M | $381.4M | |
| Operating Income | -$43.2M | -$29.1M | -$19.9M | -$21.1M | -$14.1M | |
| Net Interest Expenses | $25.7M | $25M | $14.2M | $48.9M | $19.2M | |
| EBT. Incl. Unusual Items | -$330.5M | -$29.8M | -$62.1M | -$202.4M | -$63M | |
| Earnings of Discontinued Ops. | -$6.1M | -$7.3M | -$463K | -- | -- | |
| Income Tax Expense | -$2.4M | $483K | -$43.4M | -$89.4M | -$1.4M | |
| Net Income to Company | -$334.2M | -$37.6M | -$19.2M | -$113M | -$61.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$334.2M | -$37.6M | -$19.2M | -$113M | -$61.6M | |
| Basic EPS (Cont. Ops) | -$3.94 | -$0.44 | -$0.20 | -$1.28 | -$0.81 | |
| Diluted EPS (Cont. Ops) | -$3.94 | -$0.44 | -$0.20 | -$1.28 | -$0.81 | |
| Weighted Average Basic Share | $84.9M | $86.1M | $93.7M | $111.3M | $114.7M | |
| Weighted Average Diluted Share | $84.9M | $86.1M | $93.7M | $111.3M | $114.7M | |
| EBITDA | -$240.7M | $55.7M | $20.7M | -$24.8M | $80.1M | |
| EBIT | -$302.2M | -$4.4M | -$46.5M | -$148.2M | -$38.3M | |
| Revenue (Reported) | $924.6M | $908M | $1.4B | $2B | $2.6B | |
| Operating Income (Reported) | -$43.2M | -$29.1M | -$19.9M | -$21.1M | -$14.1M | |
| Operating Income (Adjusted) | -$302.2M | -$4.4M | -$46.5M | -$148.2M | -$38.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $215.1M | $297.1M | $427.7M | $639.7M | $483.6M | |
| Revenue Growth (YoY) | -2.79% | 38.12% | 43.98% | 49.56% | -24.39% | |
| Cost of Revenues | $157.8M | $219.7M | $310.5M | $535.5M | $381.2M | |
| Gross Profit | $57.2M | $77.3M | $117.2M | $104.1M | $102.5M | |
| Gross Profit Margin | 26.61% | 26.03% | 27.41% | 16.28% | 21.19% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $58.6M | $58.9M | $89.7M | $79.1M | $78.4M | |
| Other Inc / (Exp) | $12.2M | -$5.3M | -$74.6M | -$8.8M | -$54M | |
| Operating Expenses | $73.8M | $74M | $119M | $108.6M | $102.5M | |
| Operating Income | -$16.5M | $3.3M | -$1.8M | -$4.5M | $4K | |
| Net Interest Expenses | $6.2M | $2.1M | $11.8M | $3.4M | $9.1M | |
| EBT. Incl. Unusual Items | -$10.6M | -$4.1M | -$88.2M | -$16.7M | -$63.1M | |
| Earnings of Discontinued Ops. | $1.4M | -- | -- | -- | -- | |
| Income Tax Expense | $611K | $1.2M | -$68.2M | $565K | $1.5M | |
| Net Income to Company | -$9.8M | -$5.4M | -$20M | -$17.3M | -$64.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$9.8M | -$5.4M | -$20M | -$17.3M | -$64.6M | |
| Basic EPS (Cont. Ops) | -$0.12 | -$0.06 | -$0.24 | -$0.22 | -$0.63 | |
| Diluted EPS (Cont. Ops) | -$0.12 | -$0.06 | -$0.24 | -$0.22 | -$0.63 | |
| Weighted Average Basic Share | $84.7M | $89.5M | $107.8M | $114.1M | $115.3M | |
| Weighted Average Diluted Share | $84.7M | $89.5M | $107.8M | $114.1M | $115.3M | |
| EBITDA | $11.1M | $13.2M | -$46M | $18.8M | -$28.7M | |
| EBIT | -$4.2M | -$1.9M | -$75.3M | -$10.7M | -$52.8M | |
| Revenue (Reported) | $215.1M | $297.1M | $427.7M | $639.7M | $483.6M | |
| Operating Income (Reported) | -$16.5M | $3.3M | -$1.8M | -$4.5M | $4K | |
| Operating Income (Adjusted) | -$4.2M | -$1.9M | -$75.3M | -$10.7M | -$52.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $918.5M | $989.9M | $1.5B | $2.2B | $2.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $678.8M | $719.5M | $1.1B | $1.7B | $2B | |
| Gross Profit | $239.7M | $270.5M | $356.5M | $447.4M | $365.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $216.9M | $219.8M | $300.1M | $347.5M | $262.4M | |
| Other Inc / (Exp) | -$199.2M | $6.9M | -$97.2M | -$66.6M | -$75.1M | |
| Operating Expenses | $277M | $279.8M | $381.4M | $471.1M | $375.3M | |
| Operating Income | -$37.3M | -$9.3M | -$24.9M | -$23.8M | -$9.6M | |
| Net Interest Expenses | $26.4M | $20.9M | $23.9M | $40.6M | $24.8M | |
| EBT. Incl. Unusual Items | -$262.9M | -$23.4M | -$146.1M | -$130.9M | -$109.5M | |
| Earnings of Discontinued Ops. | -$4.4M | -$8.7M | -$463K | -- | -- | |
| Income Tax Expense | -$2M | $1.1M | -$112.8M | -$20.6M | -$508K | |
| Net Income to Company | -$265.3M | -$33.1M | -$33.8M | -$110.3M | -$109M | |
| Minority Interest in Earnings | $822K | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$265.3M | -$33.1M | -$33.8M | -$110.3M | -$109M | |
| Basic EPS (Cont. Ops) | -$3.11 | -$0.38 | -$0.38 | -$1.25 | -$1.23 | |
| Diluted EPS (Cont. Ops) | -$3.11 | -$0.38 | -$0.38 | -$1.25 | -$1.23 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$173.8M | $57.9M | -$38.5M | $40M | $32.6M | |
| EBIT | -$234.5M | -$2M | -$119.9M | -$83.6M | -$80.4M | |
| Revenue (Reported) | $918.5M | $989.9M | $1.5B | $2.2B | $2.4B | |
| Operating Income (Reported) | -$37.3M | -$9.3M | -$24.9M | -$23.8M | -$9.6M | |
| Operating Income (Adjusted) | -$234.5M | -$2M | -$119.9M | -$83.6M | -$80.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $215.1M | $297.1M | $427.7M | $639.7M | $483.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $157.8M | $219.7M | $310.5M | $535.5M | $381.2M | |
| Gross Profit | $57.2M | $77.3M | $117.2M | $104.1M | $102.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $58.6M | $58.9M | $89.7M | $79.1M | $78.4M | |
| Other Inc / (Exp) | $12.2M | -$5.3M | -$74.6M | -$8.8M | -$54M | |
| Operating Expenses | $73.8M | $74M | $119M | $108.6M | $102.5M | |
| Operating Income | -$16.5M | $3.3M | -$1.8M | -$4.5M | $4K | |
| Net Interest Expenses | $6.2M | $2.1M | $11.8M | $3.4M | $9.1M | |
| EBT. Incl. Unusual Items | -$10.6M | -$4.1M | -$88.2M | -$16.7M | -$63.1M | |
| Earnings of Discontinued Ops. | $1.4M | -- | -- | -- | -- | |
| Income Tax Expense | $611K | $1.2M | -$68.2M | $565K | $1.5M | |
| Net Income to Company | -$9.8M | -$5.4M | -$20M | -$17.3M | -$64.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$9.8M | -$5.4M | -$20M | -$17.3M | -$64.6M | |
| Basic EPS (Cont. Ops) | -$0.12 | -$0.06 | -$0.24 | -$0.22 | -$0.63 | |
| Diluted EPS (Cont. Ops) | -$0.12 | -$0.06 | -$0.24 | -$0.22 | -$0.63 | |
| Weighted Average Basic Share | $84.7M | $89.5M | $107.8M | $114.1M | $115.3M | |
| Weighted Average Diluted Share | $84.7M | $89.5M | $107.8M | $114.1M | $115.3M | |
| EBITDA | $11.1M | $13.2M | -$46M | $18.8M | -$28.7M | |
| EBIT | -$4.2M | -$1.9M | -$75.3M | -$10.7M | -$52.8M | |
| Revenue (Reported) | $215.1M | $297.1M | $427.7M | $639.7M | $483.6M | |
| Operating Income (Reported) | -$16.5M | $3.3M | -$1.8M | -$4.5M | $4K | |
| Operating Income (Adjusted) | -$4.2M | -$1.9M | -$75.3M | -$10.7M | -$52.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $319M | $266.3M | $188.2M | $192.8M | $104.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $124.1M | $130.6M | $254.7M | $446.7M | $414.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $56.3M | -- | -- | -- | -- | |
| Other Current Assets | -- | $51.4M | $20.7M | $30.3M | $28.9M | |
| Total Current Assets | $547.6M | $524M | $478.1M | $683.7M | $607.1M | |
| Property Plant And Equipment | $144M | $131.6M | $136.9M | $90.2M | $79.3M | |
| Long-Term Investments | $6.5M | $5.5M | $4.5M | $4.9M | $8.6M | |
| Goodwill | $349M | $426.3M | $722.8M | $1.1B | $1.1B | |
| Other Intangibles | $265M | $279.8M | $442.8M | $752M | $680.2M | |
| Other Long-Term Assets | $27M | $19.8M | $14.8M | $20.9M | $18.6M | |
| Total Assets | $1.4B | $1.4B | $1.8B | $2.7B | $2.5B | |
| Accounts Payable | $32M | $96.1M | $57.2M | $48.2M | $96M | |
| Accrued Expenses | $73.2M | $107.2M | $111.2M | $149.8M | $66.4M | |
| Current Portion Of Long-Term Debt | $26.6M | -- | -- | -- | $171.5M | |
| Current Portion Of Capital Lease Obligations | $7.4M | $7.1M | $7.1M | $9.7M | $26.7M | |
| Other Current Liabilities | $28M | -- | -- | -- | -- | |
| Total Current Liabilities | $403.3M | $445.5M | $433.4M | $674.2M | $715.5M | |
| Long-Term Debt | $263.3M | $215.7M | $413M | $597M | $490.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $752.1M | $725.8M | $957.9M | $1.6B | $1.5B | |
| Common Stock | $859K | $908K | $1M | $1.2M | $1.2M | |
| Other Common Equity Adj | -$278K | -$362K | -$1.2M | -$1.3M | -$1.8M | |
| Common Equity | $619.6M | $693.6M | $859.4M | $1.1B | $1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $619.6M | $693.6M | $859.4M | $1.1B | $1B | |
| Total Liabilities and Equity | $1.4B | $1.4B | $1.8B | $2.7B | $2.5B | |
| Cash and Short Terms | $319M | $266.3M | $188.2M | $192.8M | $104.2M | |
| Total Debt | $289.9M | $215.7M | $413M | $597M | $662M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $236M | $210.2M | $157.5M | $165.1M | $246.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $185.1M | $179.3M | $262.8M | $427.7M | $430.5M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $33.7M | $34.3M | -- | -- | -- | |
| Other Current Assets | -- | -- | $33.8M | $24.8M | $34.7M | |
| Total Current Assets | $508.3M | $463.4M | $476M | $669.2M | $727.9M | |
| Property Plant And Equipment | $138.1M | $131.4M | $133M | $86.8M | $80.2M | |
| Long-Term Investments | $4.9M | $3.7M | $4.1M | $8.2M | $8.6M | |
| Goodwill | $349M | $426.3M | $1.1B | $1.1B | $1.1B | |
| Other Intangibles | $259.4M | $272.2M | $825.9M | $731.3M | $667.9M | |
| Other Long-Term Assets | $14.3M | $13M | $16.1M | $19M | $18.2M | |
| Total Assets | $1.3B | $1.3B | $2.6B | $2.6B | $2.7B | |
| Accounts Payable | $78.6M | $64M | $51M | $77.3M | $57.8M | |
| Accrued Expenses | $61.1M | $115.1M | $170.2M | $165.1M | $99.5M | |
| Current Portion Of Long-Term Debt | $26.6M | -- | -- | -- | $171.8M | |
| Current Portion Of Capital Lease Obligations | $7.5M | $6.4M | $4.6M | $12.7M | $35.2M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $414.5M | $382.5M | $457.6M | $659M | $739.1M | |
| Long-Term Debt | $202.1M | $282.6M | $632.3M | $597.9M | $647.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $688.3M | $727.9M | $1.3B | $1.6B | $1.7B | |
| Common Stock | $868K | $916K | $171.8M | $1.2M | $1.2M | |
| Other Common Equity Adj | -$309K | -$494K | -$1.1M | -$1.3M | -$1.7M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | $168M | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $617.3M | $611.2M | $1.3B | $1B | $935.5M | |
| Total Liabilities and Equity | $1.3B | $1.3B | $2.6B | $2.6B | $2.7B | |
| Cash and Short Terms | $236M | $210.2M | $157.5M | $165.1M | $246.5M | |
| Total Debt | $228.7M | $282.6M | $632.3M | $597.9M | $819.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$334.2M | -$37.6M | -$19.2M | -$113M | -$61.6M | |
| Depreciation & Amoritzation | $61.5M | $60M | $67.2M | $123.4M | $118.4M | |
| Stock-Based Compensation | $14.6M | $16.7M | $34M | $40.5M | $39.7M | |
| Change in Accounts Receivable | -$58.4M | -$24.8M | -$103M | -$164.7M | $32.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$16.2M | $38.7M | -$11.6M | $142.6M | $18.8M | |
| Capital Expenditures | $29.5M | $25M | $38.4M | $28.7M | $24.9M | |
| Cash Acquisitions | -- | $14.2M | $5.6M | $870K | -$7.3M | |
| Cash From Investing | $261.1M | -$15.8M | -$259.1M | -$415.5M | -$62.9M | |
| Dividends Paid (Ex Special Dividend) | -$20M | -$1.3M | -$14.9M | -$18.8M | -$20.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $30.1M | -- | $219.7M | $647.5M | $58.6M | |
| Long-Term Debt Repaid | -$16.6M | -$98.8M | -- | -$464.2M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$7.9M | -$3.9M | -$77.8M | -$63.7M | -$42.5M | |
| Cash From Financing | -$11.9M | -$29.5M | $131.5M | $281.3M | -$565K | |
| Beginning Cash (CF) | $128.5M | $361.6M | $354.9M | $215.2M | $223.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $233M | -$6.6M | -$139.1M | $8.4M | -$44.7M | |
| Ending Cash (CF) | $361.6M | $354.9M | $215.2M | $223.5M | $178.5M | |
| Levered Free Cash Flow | -$45.7M | $13.8M | -$49.9M | $113.8M | -$6.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$9.8M | -$5.4M | -$20M | -$17.3M | -$64.6M | |
| Depreciation & Amoritzation | $15.3M | $15.1M | $29.3M | $29.5M | $24.1M | |
| Stock-Based Compensation | $3.7M | $5.3M | $10.7M | $18.8M | $11.1M | |
| Change in Accounts Receivable | -$63.2M | -$47.4M | $18.5M | $17.5M | -$17M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$48.2M | -$57.4M | -$8M | $4.9M | $4.6M | |
| Capital Expenditures | $5.9M | $8.5M | $9.1M | $5.3M | $8.6M | |
| Cash Acquisitions | $9.4M | -- | $786K | -- | -- | |
| Cash From Investing | $46M | $16.8M | -$395M | -$9.7M | -$13.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -$1.1M | -$3.7M | -$5.1M | -$4.6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $256.3M | -- | $221M | |
| Long-Term Debt Repaid | -$98.4M | -- | -$37.5M | -$529K | -$62.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $36.3M | -$50.6M | -$5M | $19.4M | -$46.1M | |
| Cash From Financing | -$55.6M | -$51.4M | $379.7M | $14.9M | $107.9M | |
| Beginning Cash (CF) | $361.6M | $354.9M | $215.2M | $223.5M | $178.5M | |
| Foreign Exchange Rate Adjustment | $1K | -$104K | $50K | -$38K | $23K | |
| Additions / Reductions | -$57.8M | -$92.1M | -$23.2M | $10.1M | $99.3M | |
| Ending Cash (CF) | $303.8M | $262.8M | $192M | $233.5M | $277.8M | |
| Levered Free Cash Flow | -$54.1M | -$66M | -$17M | -$438K | -$4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$265.3M | -$33.1M | -$33.8M | -$110.3M | -$109M | |
| Depreciation & Amoritzation | $60.7M | $59.8M | $81.4M | $123.6M | $112.9M | |
| Stock-Based Compensation | $14.8M | $18.4M | $39.3M | $48.6M | $32M | |
| Change in Accounts Receivable | -$85M | -$8.9M | -$37.1M | -$165.7M | -$2.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$43.8M | $29.5M | $37.9M | $155.5M | $18.4M | |
| Capital Expenditures | $28M | $27.6M | $38.9M | $25M | $28.1M | |
| Cash Acquisitions | $9.4M | $4.8M | $6.3M | $84K | -$7.3M | |
| Cash From Investing | $317.8M | -$45M | -$670.9M | -$30.3M | -$66.3M | |
| Dividends Paid (Ex Special Dividend) | -$20M | -$2.4M | -$17.4M | -$20.2M | -$19.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $476.1M | -- | -- | |
| Long-Term Debt Repaid | -$115M | -$429K | -$37.5M | -$427.2M | -$62M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$4.1M | -$90.8M | -$32.2M | -$39.2M | -$108M | |
| Cash From Financing | -$100M | -$25.3M | $562.6M | -$83.5M | $92.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $174M | -$40.8M | -$70.3M | $41.7M | $44.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$71.9M | $1.9M | -$993K | $130.4M | -$9.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$9.8M | -$5.4M | -$20M | -$17.3M | -$64.6M | |
| Depreciation & Amoritzation | $15.3M | $15.1M | $29.3M | $29.5M | $24.1M | |
| Stock-Based Compensation | $3.7M | $5.3M | $10.7M | $18.8M | $11.1M | |
| Change in Accounts Receivable | -$63.2M | -$47.4M | $18.5M | $17.5M | -$17M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$48.2M | -$57.4M | -$8M | $4.9M | $4.6M | |
| Capital Expenditures | $5.9M | $8.5M | $9.1M | $5.3M | $8.6M | |
| Cash Acquisitions | $9.4M | -- | $786K | -- | -- | |
| Cash From Investing | $46M | $16.8M | -$395M | -$9.7M | -$13.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -$1.1M | -$3.7M | -$5.1M | -$4.6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $256.3M | -- | $221M | |
| Long-Term Debt Repaid | -$98.4M | -- | -$37.5M | -$529K | -$62.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $36.3M | -$50.6M | -$5M | $19.4M | -$46.1M | |
| Cash From Financing | -$55.6M | -$51.4M | $379.7M | $14.9M | $107.9M | |
| Beginning Cash (CF) | $361.6M | $354.9M | $215.2M | $223.5M | $178.5M | |
| Foreign Exchange Rate Adjustment | $1K | -$104K | $50K | -$38K | $23K | |
| Additions / Reductions | -$57.8M | -$92.1M | -$23.2M | $10.1M | $99.3M | |
| Ending Cash (CF) | $303.8M | $262.8M | $192M | $233.5M | $277.8M | |
| Levered Free Cash Flow | -$54.1M | -$66M | -$17M | -$438K | -$4M | |
Get EVH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EVH
Sector
P/E ratio
--
24.07x
PEG ratio
-0.99x
0.00x
P/B ratio
1.41x
1.81x
Price / LTM sales
0.54x
1.67x
Growth Metrics
EVH
Sector
Revenue growth
-24.39%
4.06%
Earnings growth
--
7.49%
Revenue (5-year growth)
30.04%
8.01%
Earnings forecast
$0.09
-$0.20
Profitability
EVH
Sector
Profitability FY 2024
$367.4M
$47.5M
Return on invested capital
-6.52%
-16.26%
Return on assets
-4.25%
-13.27%
Return on equity
-10.73%
-18.61%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
7
Balance Sheet
EVH
Sector
Total cash
$246.5M
$35.7M
Short term investments
--
$29.7M
Total assets
$2.5B
$106.9M
Long term debt
$819.3M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
